Table 5.
Group | CD4+ cell (%) | CD8+ cell (%) | CD303+ cell (%) |
---|---|---|---|
IIMs | 17.25 | 14.54 | 7.48 |
NIMs | 8.61 | 3.44 | 3.22 |
PM | 14.5 | 18.4 | 9.5 |
DM | 21.7 | 8.2 | 4.2 |
Dystrophinopathy | 7.8 | 2.8 | 1.4 |
Dysferlinopathy | 10.3 | 4.7 | 6.8 |
Group | CD4+ cell (%) | CD8+ cell (%) | CD303+ cell (%) |
---|---|---|---|
IIMs | 17.25 | 14.54 | 7.48 |
NIMs | 8.61 | 3.44 | 3.22 |
PM | 14.5 | 18.4 | 9.5 |
DM | 21.7 | 8.2 | 4.2 |
Dystrophinopathy | 7.8 | 2.8 | 1.4 |
Dysferlinopathy | 10.3 | 4.7 | 6.8 |